You are here

Article Text

Article menu
Download PDFPDF
Best evidence topic reports
BET 2

http://dx.doi.org/10.1136/emj.2010.101311

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Should I use 2.5 mg or 5 mg nebulised salbutamol in acute exacerbations of COPD?

    Report by: Sandeep Rahul Kusre, Senior House Officer

    Search checked by: Jonathan Costello, Consultant A&E

    Institution: Royal Free Hospital, London, UK

    Three-part question

    In (patients admitted with acute exacerbations of COPD) is (5 mg nebulised salbutamol superior to 2.5 mg nebulised salbutamol) at (improving lung function and reducing length of hospital stay)?

    Clinical scenario

    While working a busy nightshift in A&E you see a patient with an acute exacerbation …

    View Full Text

    Footnotes

    • Provenance and peer review Not commissioned; not externally peer reviewed.